OSE Immunotherapeutics SA (EPA:OSE)
France
· Delayed Price · Currency is EUR 3.914
-0.104 (-2.59%)
At close: Mar 9, 2026
OSE Immunotherapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 18.01 | 16.75 | 18.67 | 25.62 | 33.58 | Upgrade
|
| Short-Term Investments | 9.79 | 42.37 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 27.81 | 59.12 | 18.67 | 25.62 | 33.58 | Upgrade
|
| Cash Growth | -52.96% | 216.61% | -27.12% | -23.70% | 14.34% | Upgrade
|
| Accounts Receivable | - | 4.17 | 1.15 | 0.4 | 0.77 | Upgrade
|
| Other Receivables | - | 3.14 | 6.44 | 5.98 | 5.18 | Upgrade
|
| Receivables | - | 7.31 | 7.59 | 6.39 | 5.95 | Upgrade
|
| Prepaid Expenses | - | 2.29 | 2.75 | 3.45 | 2.96 | Upgrade
|
| Other Current Assets | 8.05 | 1.22 | 1.47 | 1.74 | 1.72 | Upgrade
|
| Total Current Assets | 35.86 | 69.93 | 30.48 | 37.2 | 44.21 | Upgrade
|
| Property, Plant & Equipment | 0.4 | 3.43 | 4.07 | 4.98 | 5.44 | Upgrade
|
| Long-Term Investments | 6.25 | 5.05 | - | - | - | Upgrade
|
| Other Intangible Assets | 43.2 | 0.11 | 0.14 | 0.17 | 0.15 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.19 | 0.2 | 0.18 | 0.17 | Upgrade
|
| Long-Term Deferred Charges | - | 43.9 | 46.26 | 48.62 | 50.97 | Upgrade
|
| Other Long-Term Assets | -1.49 | 1.36 | 0.91 | 0.64 | 0.94 | Upgrade
|
| Total Assets | 84.22 | 123.96 | 82.05 | 91.78 | 101.88 | Upgrade
|
| Accounts Payable | 8.11 | 7.72 | 9.3 | 8.54 | 9.61 | Upgrade
|
| Accrued Expenses | - | - | - | 2.92 | 3.72 | Upgrade
|
| Current Portion of Long-Term Debt | 11.98 | 7.2 | 6.4 | 3.09 | 1.61 | Upgrade
|
| Current Portion of Leases | - | 0.6 | 0.86 | 0.88 | 0.76 | Upgrade
|
| Current Income Taxes Payable | - | 2.67 | 1.89 | 0.02 | 0.01 | Upgrade
|
| Current Unearned Revenue | - | 2.03 | 0.35 | 0.81 | 1.05 | Upgrade
|
| Other Current Liabilities | 3.26 | 0 | 0.01 | 0 | 0 | Upgrade
|
| Total Current Liabilities | 23.35 | 20.22 | 18.8 | 16.27 | 16.76 | Upgrade
|
| Long-Term Debt | 23.68 | 35.66 | 35.51 | 37.23 | 30.8 | Upgrade
|
| Long-Term Leases | - | 2.68 | 3.03 | 3.59 | 3.97 | Upgrade
|
| Long-Term Unearned Revenue | - | 0.1 | - | - | - | Upgrade
|
| Pension & Post-Retirement Benefits | - | 0.42 | 0.43 | 0.43 | 0.42 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.07 | 1.07 | 1.31 | 1.51 | 1.75 | Upgrade
|
| Other Long-Term Liabilities | 2.6 | - | - | 0.09 | 0.29 | Upgrade
|
| Total Liabilities | 50.7 | 60.15 | 59.08 | 59.12 | 53.99 | Upgrade
|
| Common Stock | 33.52 | 4.39 | 4.33 | 3.71 | 3.71 | Upgrade
|
| Additional Paid-In Capital | - | 77.74 | 76.64 | 65.61 | 65.61 | Upgrade
|
| Retained Earnings | - | 37.45 | -23 | -17.76 | -16.85 | Upgrade
|
| Treasury Stock | - | -0.45 | -0.41 | -0.55 | -0.16 | Upgrade
|
| Comprehensive Income & Other | - | -55.32 | -34.59 | -18.35 | -4.41 | Upgrade
|
| Shareholders' Equity | 33.52 | 63.81 | 22.98 | 32.66 | 47.89 | Upgrade
|
| Total Liabilities & Equity | 84.22 | 123.96 | 82.05 | 91.78 | 101.88 | Upgrade
|
| Total Debt | 35.66 | 46.13 | 45.8 | 44.79 | 37.13 | Upgrade
|
| Net Cash (Debt) | -7.85 | 12.99 | -27.13 | -19.17 | -3.55 | Upgrade
|
| Net Cash Per Share | -0.36 | 0.51 | -1.39 | -1.03 | -0.20 | Upgrade
|
| Filing Date Shares Outstanding | 22 | 22.31 | 21.59 | 18.45 | 18.49 | Upgrade
|
| Total Common Shares Outstanding | 22 | 21.9 | 21.59 | 18.46 | 18.49 | Upgrade
|
| Working Capital | 12.51 | 49.71 | 11.68 | 20.93 | 27.45 | Upgrade
|
| Book Value Per Share | 1.52 | 2.91 | 1.06 | 1.77 | 2.59 | Upgrade
|
| Tangible Book Value | -9.69 | 63.7 | 22.84 | 32.49 | 47.74 | Upgrade
|
| Tangible Book Value Per Share | -0.44 | 2.91 | 1.06 | 1.76 | 2.58 | Upgrade
|
| Buildings | - | 0.32 | 0.32 | 0.31 | 0.36 | Upgrade
|
| Machinery | - | 1.74 | 1.67 | 1.71 | 1.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.